about
Charcot-Marie-Tooth disease: genetic and clinical spectrum in a Spanish clinical series.Genetic and constitutional factors are major contributors to substantia nigra hyperechogenicity.Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder.Brain signal intensity changes as biomarkers in amyotrophic lateral sclerosis.Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain.Safety and efficacy of botulinum toxin A for the treatment of spasticity in amyotrophic lateral sclerosis: results of a pilot study.The role of DNAJB2 in amyotrophic lateral sclerosis.Monitoring Progression of Amyotrophic Lateral Sclerosis Using Ultrasound Morpho-Textural Muscle Biomarkers: A Pilot Study.Quantitative Muscle Ultrasonography Using Textural Analysis in Amyotrophic Lateral Sclerosis.Muscular Echovariation: A New Biomarker in Amyotrophic Lateral Sclerosis.Phenotype and natural history of inherited neuropathies caused by HSJ1 c.352+1G>A mutation.Urodynamic findings in amyotrophic lateral sclerosis patients with lower urinary tract symptoms: Results from a pilot study.Clinical and neuroimaging characterization of two C9orf72-positive siblings with amyotrophic lateral sclerosis and schizophrenia.Age at surgery as a predictor of cognitive improvements in patients with drug-resistant temporal epilepsy.Phenotypical features of two patients diagnosed with PHARC syndrome and carriers of a new homozygous mutation in the ABHD12 gene.Inflammatory amyloid angiopathy.Primary lateral sclerosis and hereditary spastic paraplegia in sporadic patients. An important distinction in descriptive studies.Sonoelastography for the Assessment of Muscle Changes in Amyotrophic Lateral Sclerosis: Results of a Pilot StudyNew insights into the pathophysiology of fasciculations in amyotrophic lateral sclerosis: An ultrasound studyImaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral SclerosisCharacterising the phenotype and mode of inheritance of patients with inherited peripheral neuropathies carrying mutations[Cerebrovascular disease in childhood: a retrospective analysis of hospital admissions in a tertiary hospital in the community of Valencia in the last ten years]Mesencephalic area measured by transcranial sonography in the differential diagnosis of parkinsonismDecreased spasticity in primary lateral sclerosis after botulinum toxin injection: A case reportAnalysis of the diagnostic pathway and delay in patients with amyotrophic lateral sclerosis in the Valencian CommunityClinical spectrum of BICD2 mutationsQuantitative neuromuscular ultrasound analysis as biomarkers in amyotrophic lateral sclerosisThe width of the third ventricle associates with cognition and behaviour in motor neuron diseaseFacial onset sensory and motor neuronopathy: a motor neuron disease with an oligogenic origin?Urinary symptoms in patients with amyotrophic lateral sclerosis
P50
Q37251629-48A62AD9-B1A7-4F82-8EF6-560CEABD98EAQ38645895-9E8AE610-459E-4789-902F-45A6D7C42911Q38752800-DBFF8DE8-FD07-4212-A1C0-E7E7793E0EF1Q47995491-52FBBBBB-C475-40DE-9B31-57D5818FF1CBQ48090963-6BDAD520-DDDF-47F8-B8E8-1BCE16CC80D5Q48172485-74A54B4F-28C3-4B36-BEC1-A888A4494C40Q48662898-4E56C1B7-20B2-40F7-8878-8BB7C657549DQ50178845-EF2C1F5E-B350-4B63-8958-B597B700AD47Q50206143-C6C3B7E6-8E3D-4250-A793-CFC35EB2582FQ50211117-7513738C-C721-4BED-8B10-BF4E36EEAD3AQ50244245-8604AE5F-BA7F-41E9-984F-7CF9AE41A7A5Q50254720-93693EC9-E74E-4730-8B68-20D54723F655Q50434648-F17B70D2-D3CF-4FD0-9BD8-498D906DC1B0Q50444184-38013875-FAC7-4A7B-8EEE-450F9B4E4C94Q52639781-370F92D1-4132-4DD6-9DC1-73143E90D46CQ53331569-D3FAF841-5D69-42F0-A73B-F8F8ADB2350CQ54269925-BEC494EB-B036-45AF-8B66-6312E0CDC67CQ57065793-3B9329A0-B152-4895-A260-2835CF0A45CDQ57191332-E520D7DB-C647-4CE6-B69A-2F08F59C9EB0Q58556498-EAB5FBC1-1315-4C0F-8206-FA3893E1842CQ58556969-354BA2AE-418B-4D12-96A9-1874AAFAD382Q83130312-35EFABB9-D5A4-4466-8A2D-82F9B46123AEQ86821906-5E08374B-806F-48AF-AAF5-51F7B016E759Q87445194-48FF7F5A-B7C6-4785-917F-D3AB90335ED8Q89106283-5DA843FC-1F0D-48EC-98EE-74C05C40331DQ89707664-A540A953-7132-4614-A9CB-995CEA5F0396Q91149991-67DF4E4A-B240-4AED-9867-7F08816D3139Q91294534-DB11FCE7-8105-406E-9D72-840A0C2643E7Q92483743-29CB172D-2596-4F1E-96A3-6EA1E4B7ED90Q92716707-27F5BE10-319A-416F-8345-5642E7E6E0DC
P50
description
researcher ORCID ID = 0000-0002-3043-7938
@en
name
Juan Francisco Vázquez Costa
@ast
Juan Francisco Vázquez Costa
@en
Juan Francisco Vázquez Costa
@es
Juan Francisco Vázquez Costa
@nl
type
label
Juan Francisco Vázquez Costa
@ast
Juan Francisco Vázquez Costa
@en
Juan Francisco Vázquez Costa
@es
Juan Francisco Vázquez Costa
@nl
prefLabel
Juan Francisco Vázquez Costa
@ast
Juan Francisco Vázquez Costa
@en
Juan Francisco Vázquez Costa
@es
Juan Francisco Vázquez Costa
@nl
P108
P108
P1153
54785443500
P21
P31
P496
0000-0002-3043-7938